KKR & Co chief financial officer Robert Lewin has warned that some private equity firms will disappear as the sector enters a period of consolidation amid a prolonged slowdown in dealmaking and a squeeze on GPs that over-invested during the 2021–2022 boom, according op a report by Bloomberg.

Private equity giant TPG and its portfolio company Musixmatch have been ordered to face an antitrust lawsuit brought by Canadian rival LyricFind, after a US judge ruled there was sufficient evidence to proceed on key claims, according to a report by Reuters.

CVC Capital Partners, one of Europe’s largest private capital managers, said investor demand for European exposure is accelerating as limited partners rebalance away from the US, according to a report by Bloomberg.

Apollo Global Management has reached a settlement with two former senior executives of its insurance affiliate Athene Holding, resolving a long-running dispute just days before the case was due to go to trial in New York, according to a report by Bloomberg.

CVC Capital Partners, one of the world’s largest private equity firms, reported half-year net profit of €396m ($464m), in line with analyst expectations, with consensus forecasts having projected €393m, according to a report by Reuters.

Blackstone has confirmed the acquisition of a landmark office property in Paris for around €700m ($819m), highlighting renewed appetite among private equity real estate investors for prime European office assets, according to a report by Reuters.

North American mid-market private equity and venture capital firms have been increasingly turning to third party providers for a range of fund administration services and this trend is only set to continue over the next two years, according to new research from Ocorian.

Dutch buyout firm Main Capital Partners is aiming to more than double its assets under management to €15bn within three years, as US institutional demand for European assets accelerates, according to a report by Bloomberg.

France’s heavily-indebted private equity-owned medical laboratory groups, including EQT-owned Cerba, face mounting pressure following a government-led audit recommending profit caps and regulatory reforms to curb outsized margins in the sector, according to a report by the Financial Times.